These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 38794269)

  • 1. In Vitro Human Liver Model for Toxicity Assessment with Clinical and Preclinical Instrumentation.
    Madorran E; Kocbek Šaherl L; Rakuša M; Munda M
    Pharmaceutics; 2024 Apr; 16(5):. PubMed ID: 38794269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperation of liver cells in health and disease.
    Kmieć Z
    Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term coculture strategies for primary hepatocytes and liver sinusoidal endothelial cells.
    Bale SS; Golberg I; Jindal R; McCarty WJ; Luitje M; Hegde M; Bhushan A; Usta OB; Yarmush ML
    Tissue Eng Part C Methods; 2015 Apr; 21(4):413-22. PubMed ID: 25233394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular vesicles derived from liver sinusoidal endothelial cells inhibit the activation of hepatic stellate cells and Kupffer cells in vitro.
    Wang J; Wu Z; Xia M; Salas SS; Ospina JA; Buist-Homan M; Harmsen MC; Moshage H
    Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167020. PubMed ID: 38244390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D hepatic cultures simultaneously maintain primary hepatocyte and liver sinusoidal endothelial cell phenotypes.
    Kim Y; Rajagopalan P
    PLoS One; 2010 Nov; 5(11):e15456. PubMed ID: 21103392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Rodent Model of Human-Dose-Equivalent 5-Fluorouracil: Toxicity in the Liver, Kidneys, and Lungs.
    da Silva MC; Fabiano LC; da Costa Salomão KC; de Freitas PLZ; Neves CQ; Borges SC; de Souza Carvalho MDG; Breithaupt-Faloppa AC; de Thomaz AA; Dos Santos AM; Buttow NC
    Antioxidants (Basel); 2023 Apr; 12(5):. PubMed ID: 37237871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of liver function in chronic liver disease: An identity crisis.
    Berasain C; Arechederra M; Argemí J; Fernández-Barrena MG; Avila MA
    J Hepatol; 2023 Feb; 78(2):401-414. PubMed ID: 36115636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver organ-on-chip models for toxicity studies and risk assessment.
    Messelmani T; Morisseau L; Sakai Y; Legallais C; Le Goff A; Leclerc E; Jellali R
    Lab Chip; 2022 Jun; 22(13):2423-2450. PubMed ID: 35694831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic priming in chronic liver disease impacts the transcriptional and genetic landscapes of hepatocellular carcinoma.
    Gallon J; Coto-Llerena M; Ercan C; Bianco G; Paradiso V; Nuciforo S; Taha-Melitz S; Meier MA; Boldanova T; Pérez-Del-Pulgar S; Rodríguez-Tajes S; von Flüe M; Soysal SD; Kollmar O; Llovet JM; Villanueva A; Terracciano LM; Heim MH; Ng CKY; Piscuoglio S
    Mol Oncol; 2022 Feb; 16(3):665-682. PubMed ID: 34863035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Scavenger Function of Liver Sinusoidal Endothelial Cells in Health and Disease.
    Bhandari S; Larsen AK; McCourt P; Smedsrød B; Sørensen KK
    Front Physiol; 2021; 12():757469. PubMed ID: 34707514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptomic Cross-Species Analysis of Chronic Liver Disease Reveals Consistent Regulation Between Humans and Mice.
    Holland CH; Ramirez Flores RO; Myllys M; Hassan R; Edlund K; Hofmann U; Marchan R; Cadenas C; Reinders J; Hoehme S; Seddek AL; Dooley S; Keitel V; Godoy P; Begher-Tibbe B; Trautwein C; Rupp C; Mueller S; Longerich T; Hengstler JG; Saez-Rodriguez J; Ghallab A
    Hepatol Commun; 2022 Jan; 6(1):161-177. PubMed ID: 34558834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The principles of directed cell migration.
    SenGupta S; Parent CA; Bear JE
    Nat Rev Mol Cell Biol; 2021 Aug; 22(8):529-547. PubMed ID: 33990789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental liver models: From cell culture techniques to microfluidic organs-on-chip.
    Polidoro MA; Ferrari E; Marzorati S; Lleo A; Rasponi M
    Liver Int; 2021 Aug; 41(8):1744-1761. PubMed ID: 33966344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver organoid as a 3D in vitro model for drug validation and toxicity assessment.
    Brooks A; Liang X; Zhang Y; Zhao CX; Roberts MS; Wang H; Zhang L; Crawford DHG
    Pharmacol Res; 2021 Jul; 169():105608. PubMed ID: 33852961
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.